NDC 10122-180 – Lamzede

Velmanase Alfa-tycv 10 mg/1 · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug

Product NDC10122-180

Product details

Brand name
Lamzede
Generic name
Velmanase alfa-tycv
Labeler
Chiesi USA, Inc.
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing category
BLA · BLA761278
Marketed since
March 1, 2023
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Lamzede →

Package NDC codes (3)

Package NDCDescriptionSince
10122-180-021 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-02)Mar 1, 2023
10122-180-055 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-05)Mar 1, 2023
10122-180-1010 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-10)Mar 1, 2023